Literature DB >> 7884726

Response of canine mast cell tumors to treatment with oral prednisone.

D L McCaw1, M A Miller, G K Ogilvie, S J Withrow, W G Brewer, M K Klein, F W Bell, S K Anderson.   

Abstract

Twenty-five dogs with naturally occurring mast cell tumors were treated with daily oral prednisone (1 mg/kg) for 28 days. Five dogs (20%) had reduction in tumor volume and were considered responders. Four of these underwent partial remission and one underwent complete remission. Survival times for the five responders were 3, 5, 6, 7.5, and greater than 28 months, respectively. We therefore conclude that prednisone is effective in some canine mast cell tumors. Further studies are indicated to determine the most effective dose of prednisone, the appropriate duration of treatment, and the efficacy in more benign mast cell tumors, and in combination with other forms of therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7884726     DOI: 10.1111/j.1939-1676.1994.tb03259.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  7 in total

1.  Use of a reverse saphenous skin flap for the excision of a grade II mast cell tumor on the hind limb of a dog.

Authors:  Catherine Brière
Journal:  Can Vet J       Date:  2002-08       Impact factor: 1.008

2.  The effect of prednisone on histologic and gross characteristics in canine mast cell tumors.

Authors:  Ken J Linde; Stephen L Stockdale; Michael B Mison; James A Perry
Journal:  Can Vet J       Date:  2021-01       Impact factor: 1.008

3.  Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

Authors:  K S Carlsten; C A London; S Haney; R Burnett; A C Avery; D H Thamm
Journal:  J Vet Intern Med       Date:  2011-12-19       Impact factor: 3.333

4.  Increased risk of select glucocorticoid adverse events in dogs of higher body weight.

Authors:  Loren S Sri-Jayantha; Michael T Doornink; Bridget K Urie
Journal:  Can Vet J       Date:  2022-01       Impact factor: 1.008

5.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

6.  Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.

Authors:  J H Burton; R O Venable; D M Vail; L E Williams; C A Clifford; S M Axiak-Bechtel; A C Avery; D H Thamm
Journal:  J Vet Intern Med       Date:  2015-06-25       Impact factor: 3.333

7.  Evaluation of Tumor Grade and Proliferation Indices before and after Short-Course Anti-Inflammatory Prednisone Therapy in Canine Cutaneous Mast Cell Tumors: A Pilot Study.

Authors:  Shawna Klahn; Nikolaos Dervisis; Kevin Lahmers; Marian Benitez
Journal:  Vet Sci       Date:  2022-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.